Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer
Francis Arena Clinical Research Alliance, Lake Success, New York, NY, USAAbstract: Breast cancer is a leading cause of cancer-related death worldwide. Approximately 75% of breast cancer is hormone receptor-positive (HR+) and is managed with endocrine therapies. However, relapse or disease progressi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-10-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/clinical-implications-of-recent-studies-using-mtor-inhibitors-to-treat-peer-reviewed-article-CMAR |